Home
About
Overview
Sharing Data
ORCID
Help
History (69)
Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice.
An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancer.
Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series.
A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer.
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy.
See All 69 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy.
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy. J Clin Neurosci. 2015 Dec; 22(12):1978-9.
View in:
PubMed
subject areas
Adult
Brain Neoplasms
Carcinoma, Non-Small-Cell Lung
Female
Gene Rearrangement
Humans
Lung Neoplasms
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
authors with profiles
Martin Nicholas
Ravi Salgia
Yasmin Hasan